Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2026

Conditions
Celiac Disease
Interventions
DRUG

Ferinject

Experimental group will receive intravenous iron infusion (Ferinject©: 15 mg/kg in NaCl solution IV) at randomization, 2weeks after randomization, 4weeks after randomization, and then every month for a total of one year. Comparison group will not receive any intravenous treatment. Both experimental and comparison groups will receive an oral iron supplementation (100 mg/day).

DRUG

oral iron

All patients will receive an oral iron supplementation (100mg/day).

Trial Locations (1)

75014

Hôpital Cochin, Paris

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER